IP Verse

Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses Thereof

Patent No. EP2870250 (titled "Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses Thereof") was filed by Biogen Idec MA on Jul 5, 2013. The application was issued on Jun 29, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EUROPEAN OPPOSITIONSJan 18, 2019ELKINGTON AND FIFE
FH SERVICESJan 17, 2019BECK GREENER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2870250

BIOGEN IDEC MA
Application Number
EP13813225A
Filing Date
Jul 5, 2013
Status
Patent Maintained As Amended
May 27, 2022
Publication Date
Jun 29, 2022
External Links
Slate, Register , Google Patents